|
Advaxis, Inc. - Company Profile Snapshot
| Company Profile: |
Advaxis, Inc. |
| Ticker: |
ADXS |
| Exchanges: |
OTC |
| 2008 Sales: |
65,736 |
| Major Industry: |
Drugs, Cosmetics & Health Care |
| Sub Industry: |
Ethical Drug Manufacturers |
| Country: |
UNITED STATES |
| Employees: |
9 |
Business Description
Advaxis, Inc.. The Group's principal activity is researching and developing new cancer-fighting techniques. The Group develops cancer vaccines targeting cervical, breast, melanoma, ovarian, lung and other cancers. The Group's products are Lovaxin C, Lovaxin B, Lovaxin P, Lovaxin X, Lovaxin T. The Group also undertakes process development programs for recombinant protein and gene therapy products. It's in the development stage and its operations are subject to all of the risks inherent in an emerging business enterprise.
|
Not the Report you are looking for?
Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
